Clinical trial

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

NCT01726335

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-01

PhasePHASE4

Study timeline

Study start (unknown)2006-01-01Date precision: month

Registry last updated2014-04-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Risperidone prolonged releaseDRUG

Sponsors & collaborators

Janssen-Cilag Ltd.lead sponsor

Mapped research locations

São PauloBrazil1 Rio de JaneiroBrazil1 Porto AlegreBrazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01726335 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.